Luvadaxistat

N/A

Report date: 2026/01/12 20:00:53
NME

Base Information

Drug NameLuvadaxistat
Drug Alias NameTAK-831TAK-831-1001NBI-1065844
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionD-amino-acid oxidase inhibitors
TargetsD-amino-acid oxidase
Therapy Area/IndicationsSchizophreniaFriedreich AtaxiaCerebellar Ataxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaUnited States +[11
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSchizophreniaFriedreich AtaxiaCerebellar Ataxia

Other Information

ATC CodeN/A
Related LinksN/A